← Back to Browse
ProductDiagnostic Tests

Aiplex™ Pulse Wave Velocity Assessment Tool

South Korea

Diagnostic tool measuring pulse wave velocity as an indicator of arterial stiffness and cardiovascular health status. Provides objective assessment of vascular function through non-invasive pulse wave recording methodology.

Manufactured by

South Korea

Harvey Cardio Co., Ltd. – Innovating Cardiovascular Disease Screening Through Precision Technology Havey Cardio is setting a new standard in cardiovascular and cerebrovascular screening through our proprietary Pulse Wave Transit Time Ratio (PWR) analysis technology. 1. Technological Innovation: Unmatched Precision - Traditional Pulse Wave Velocity (PWV) methods often suffer from measurement errors depending on the patient’s body type or the practitioner’s technique. We have overcome these limitations by developing a technology that analyzes pulse wave data based on time ratios alone, eliminating the need for distance measurements. This breakthrough has been clinically validated, achieving a high diagnostic accuracy of approximately 82% in sensitivity and specificity. 2. Practical Innovation: Accessibility and Ease of Use - Equipped with our self-developed, high-sensitivity digital pressure sensors, our solution enables the simultaneous, accurate, and convenient measurement of pulse waves from multiple body points. We provide an environment where cardiovascular health can be managed easily not only in specialized general hospitals but also in primary care clinics, making preventive screening more accessible than ever. 3. Future Innovation: Synergy Between AI and Expertise - Our robust R&D ecosystem is led by executives with extensive experience in the pharmaceutical and healthcare industries, alongside a dedicated team of Ph.D. researchers in biomedical engineering. We are currently advancing a next-generation diagnostic platform that utilizes Artificial Intelligence (AI) simulations to detect subtle anomalies in pulse wave signals. Our Vision: Following our certification as a Venture Business and the official recognition of our Corporate R&D Center in 2025, Harvey Cardio is now poised for a major leap forward. Our mission is clear: to contribute to global health by developing innovative methods for the early detection and prevention of cardiovascular diseases, ensuring a healthier life for all humanity.

✦ Product-Specific Coverage

AI supplier coverage for this product

Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.

Generated for this product

AI-matched supplier coverage based on related product alternatives.

0
Relevant manufacturers
matched to this product
0
Relevant products analyzed
for supplier coverage
0
Sourcing countries
identified

Top sourcing countries

1China
5 relevant products
2Austria
3 relevant products
3South Korea
2 relevant products

See the full supplier coverage for this product

Get free access to all relevant manufacturers, sourcing countries, and product alternatives.

Get Free Access →

Free for medical industry professionals.

AI-Matched Alternative Products

from other manufacturers

AI-Matched Alternative Products

from other manufacturers

3 of 10 closest product alternatives

10 products

7 more product alternatives available

Create a free account to compare more product alternatives and supplier options.

Get Free Access →

© 2026 Suplivia · Home · Browse Products